{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT01776840_SHINE\\NCT01776840_SHINE_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Intent-to-Treat Population",
        "text": "The ITT population includes all subjects who are randomized. This population will be used for the primary efficacy analysis and all other efficacy analyses, unless otherwise specified.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "ITT",
        "populationDescription": "The ITT population includes all subjects who are randomized. This population will be used for the primary efficacy analysis and all other efficacy analyses, unless otherwise specified.",
        "criteria": "All randomized subjects"
      },
      {
        "id": "pop_2",
        "name": "Safety Analysis Set",
        "text": "The Safety Analysis Set includes all randomized subjects who received at least one dose of any study treatment (ibrutinib/placebo, bendamustine, or rituximab).",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "populationDescription": "The Safety Analysis Set includes all randomized subjects who received at least one dose of any study treatment (ibrutinib/placebo, bendamustine, or rituximab).",
        "criteria": "Randomized AND received >=1 dose of any study treatment"
      },
      {
        "id": "pop_3",
        "name": "Per-Protocol Set",
        "text": "The per-protocol set is a subset of the ITT population, excluding subjects with major protocol deviations that may impact the primary efficacy endpoint. The specific criteria for exclusion will be finalized prior to database lock.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "populationDescription": "The per-protocol set is a subset of the ITT population, excluding subjects with major protocol deviations that may impact the primary efficacy endpoint. The specific criteria for exclusion will be finalized prior to database lock.",
        "criteria": "ITT population AND no major protocol deviations"
      },
      {
        "id": "pop_4",
        "name": "PK Analysis Set",
        "text": "The PK analysis set includes all subjects who received at least one dose of ibrutinib and have at least one evaluable PK sample.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "populationDescription": "The PK analysis set includes all subjects who received at least one dose of ibrutinib and have at least one evaluable PK sample.",
        "criteria": "Received >=1 dose of ibrutinib AND >=1 evaluable PK sample"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "code": "AGE",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age at baseline in years"
      },
      {
        "id": "char_2",
        "name": "sMIPI score",
        "code": "SMIPI_SCORE",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "sMIPI score",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Simplified MCL international prognostic index score (low risk [0-3] vs. intermediate risk [4-5] vs. high risk [6-11])"
      },
      {
        "id": "char_3",
        "name": "TP53 Mutation Status",
        "code": "TP53_MUTATION_STATUS",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "TP53 Mutation Status",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Presence or absence of TP53 mutation"
      }
    ],
    "summary": {
      "populationCount": 4,
      "characteristicCount": 3
    }
  }
}